ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 667449 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 667449; 2) Community: the network communities that were significantly associated with the response to NSC 667449; 3) Molecule: the relationships between components within communities and NSC 667449; 4) MDR: the compounds that were significantly associated with the NSC 667449.

NSC Compound Enrichment Correlation
NSC 694509 Null 0.0352028253287042 0.039516123
NSC 699934 Null 0.0352028253287042 0.1742771
NSC 700906 [1-Methyl-4-[1-methyl-4-(3-methoxysulfonyl)propanamido]pyrole-2-carboxamido]propane 0.0352028253287042 0.169792
NSC 706992 Null 0.0352028253287042 0.21359762
NSC 719667 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one 0.0352028253287042 0.41722904
NSC 725098 Null 0.0352028253287042 0.41899398
NSC 726217 Combretastatin A4-analogue 0.0352028253287042 0.54077612
NSC 731701 1[(4-n-butyloxyCarbonyl)piperazine-1-yl]diazene-1-ium-1,2-di olate 0.0352028253287042 0.11904438
NSC 731704 1-[4-Ethoxycarbonyl)homopiperazine-1-yl]diazen-1-ium-1,2-dio late. 0.0352028253287042 0.47310807
NSC 748902 [(20S)-20-(N,N-dimethylamino)- 3a-(tigloylamino)-5a-preg-2a-ol] 0.0352028253287042 0.3538433
Total:127  Current:94    [First] [Prev] [Next] [Last]